404 POSTER A phase I study of oral administration of the histone deacetylase (HDAC) inhibitor belinostat in patients (pts) with advanced solid tumors

2008 ◽  
Vol 6 (12) ◽  
pp. 127 ◽  
Author(s):  
W. Kelly ◽  
D. Petrylak ◽  
G. Blumenschein ◽  
U. Lassen ◽  
P. Buhl Jensen ◽  
...  
Keyword(s):  
Oral Administration ◽  
Phase I ◽  
Solid Tumors ◽  
Histone Deacetylase ◽  
Hdac Inhibitor ◽  
Phase I Study ◽  
Advanced Solid Tumors

A phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors

2014 ◽  
Vol 33 (1) ◽  
pp. 225-232 ◽  
Author(s):  
Nuttapong Ngamphaiboon ◽  
Grace K. Dy ◽  
Wen Wee Ma ◽  
Yujie Zhao ◽  
Thanyanan Reungwetwattana ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Histone Deacetylase ◽  
Hdac Inhibitor ◽  
Phase I Study ◽  
Advanced Solid Tumors

A phase I, pharmacokinetic (PK) and pharmacodynamic (PD) study of a novel histone deacetylase (HDAC) inhibitor LAQ824 in patients with advanced solid tumors

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3022-3022 ◽  
Author(s):  
E. K. Rowinsky ◽  
S. Pacey ◽  
A. Patnaik ◽  
A. O'Donnell ◽  
M. M. Mita ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Histone Deacetylase ◽  
Hdac Inhibitor ◽  
Advanced Solid Tumors
Sign in / Sign up

Export Citation Format

Share Document